6,786 patients participated in clinical trials of Nalfon with less than 2% discontinuing due to Gastrointestinal related side effects. Of these patients, 188 were followed for one year. 1
Nalfon has extensive healthcare provider use with over 42 years of prescribing. 2
Nalfon is not combined with a Proton Pump Inhibitor (PPI) or H2 Antagonist which could potentially lead to additional safety concerns in long term use.
Nalfon is 99% bound to plasma protein for greater Cox-2 inhibition.
Nalfon has no absorption interference when given with commonly prescribed antacids containing aluminum and magnesium hydroxide.
Nalfon begins to relieve pain in as little as 15-30 minutes.
Nalfon is indicated:
INDICATION AND USAGE
What is NALFON (fenoprofen calcium)?
NALFON is a nonsteroidal, anti-inflammatory, antiarthritic drug. Carefully consider the potential benefits and risks of NALFON and other treatment options before deciding to use NALFON. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. After observing the response to initial therapy with NALFON, the dose and frequency should be adjusted to suit an individual patient's needs. Total daily dosage should not exceed 3,200 mg. NALFON may be administered with meals or with mile. The smallest dose that yields acceptable control should be employed.
NALFON is indicated for relief of mild to moderate pain in adults and for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.